Sign in

CIK 0001512762 · Accelerated filer<br>Smaller reporting company

Coherus Oncology, Inc.

Sign in to watch
Ticker
CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273615821
Phone
(650) 649-3530
Business address
C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
Former names
Coherus BioSciences, Inc., BioGenerics, Inc.
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 8-K Event Delisting notice
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 8-K Event Shareholder vote results
  13. 8-K Event Bylaws or fiscal year change · Regulation FD disclosure
  14. 4 Open-market sale Director sold 99,988 shares at $0.74 ($73,881)
  15. SC TO-I/A Deal Tender Offer Statement by Issuer
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. ARS Other Annual Report to Security Holders

Page 4 of 47 · 923 filings